PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics.PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 6, 2022 | Post-IPO Debt | $15M | 1 | Kreos Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kreos Capital | Yes | Post-IPO Debt |